The University Compliance Office announces publication of the July 2016 issue of their quarterly newsletter, Compliance 411.
Among the topics in this issue are Responsible Conduct of Research at UAB; new Recertification of Effort Form and process; a profile of Research Integrity Officer Pam Bounelis, PhD; defining fabrication, falsification and plagiarism; new research data management requirements; and the new chemical inventory system.
Your comments and feedback regarding Compliance 411 are welcome; please contact email@example.com.
Currently, Fee for Service (FFS) agreements are processed at UAB by University Contracts and are assessed a 5% of revenue administrative processing fee. As Facilities and Administrative (F&A) costs are not currently assessed on those FFS activities related to research, UAB academic units do not receive any F&A distributions in support of their research missions, despite the fact that these FFS activities result in true research infrastructure expenses. In addition, current FFS activities are not counted toward UAB’s national metrics on research expenditures (e.g., NSF HERD, etc).
As such, and consistent with practices of peer institutions, all agreements (and contract renewals) with terms beginning on or after July 1, 2016 for research-related FFS contracts will be processed by the Office of Sponsored Programs (OSP) and be assessed F&A at a rate of 30% on cash received. Budgets for research-related FFS contracts should include recovery of full direct costs in accordance with the University’s Direct Costs Policy (available on Financial Affairs website) and the appropriate F&A rate as described above.
The UAB Office of Sponsored Programs is pleased to announce the newly revised procedure for review of NIH proposal submissions for large submission deadlines involving NIH Research Project Grants (R01), Research Career Development Awards (K) and Research Fellowship (F) proposals. In order to review NIH proposals as quickly as possible, OSP has implemented a proposal review pool which will allow OSP to introduce additional reviewers to assist with proposal review when needed.
NIH proposal submissions to OSP for deadline dates of June 5th and July 5th (R01), June 12th and July 12th (K) and August 8th and 13th (F), will be assigned rotating through a pool of reviewers instead of an assignment to a specific officer by department. The reviewer will be identified in the Receipt of Submission email once a complete submission is received by OSP. This change is effective immediately.
NOTE: This is only applicable to new NIH proposal submissions for the above mentioned NIH deadlines. All other NIH proposal submission deadlines will be routed to the officer assigned to your specific department. All NIH awards will continue to be processed by the OSP officer assigned to your specific area.
Please continue to follow the OSP Review Plan to ensure that your reviewer has sufficient time to properly review the proposal.
Please forward any questions regarding the NIH proposal review process to Tim Parker at firstname.lastname@example.org or email@example.com.
The Gregory Fleming James Cystic Fibrosis Research Center is soliciting application for two slots on our Research Development Project Research Training Core for partial funding to help pay for trainees. One slot is for a graduate student, and one slot is for a postdoc.
The Research Training Core is designed to provide support for one year at a time. The Graduate Student slot will total $12,500 total towards stipend, tuition and fees total per year. The PostDoc slot will pay $43,680 total per year towards salary and fringe.
Since 2001, Alzheimer’s of Central Alabama (ACA) has funded 23 research grants at UAB, the University of Alabama and Auburn University. The purpose of this competitive grant program is to help supplement research in the field and to stimulate junior investigator interest in this area.
The Gregory Fleming James Cystic Fibrosis Research Center is soliciting application for pilot and feasibility projects to support new research initiatives in cystic fibrosis pathophysiology and intervention. The pilot and feasibility mechanism is designed to provide support for a limited time (two years, up to $75,000/year direct costs for translational research). Projects should test innovative hypotheses that may have significant impact on basic or clinical aspects of the disease and lead to preliminary data for independent grants in the area of cystic fibrosis science.